COMMUNIQUÉS West-GlobeNewswire

AB Science : Stonegate Capital Partners actualise sa couverture de l'action AB Science avec un objectif de cours de 4,25 EUR par action
02/06/2026
COMMUNIQUÉ DE PRESSE STONEGATE CAPITAL PARTNERS ACTUALISE SA COUVERTURE DE L'ACTION AB SCIENCE AVEC UN OBJECTIF DE COURS DE 4,25 EUR PAR ACTION EN VALEUR MÉDIANE, SUR LA BASE DES FLUX DE TRÉSORERIE ACTUALISÉS Paris, 2 [...]
FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients
02/06/2026
Guidance shows how sponsors can build on existing science, reducing redundant testing and accelerating treatments for patients with rare and life-threatening diseases Silver Spring, MD, June 02, 2026 (GLOBE NEWSWIRE [...]
Point d’avancement sur le projet Carbios - Wankai en Chine
02/06/2026
Clermont-Ferrand (France), 2 juin 2026 (17h45 CEST). Carbios (Euronext Growth Paris : ALCRB) fait le point sur l’avancement de son partenariat stratégique avec Wankai New Materials (« Wankai ») dans le domaine du [...]
GENFIT : Assemblée Générale Mixte du 15 juin 2026 - Lettre aux actionnaires
02/06/2026
Chers Actionnaires, Nous avons le plaisir de vous adresser, en pièce jointe, la Lettre aux actionnaires de GENFIT publiée à l’approche de notre Assemblée Générale Mixte du 15 juin 2026. Cette lettre revient sur les [...]
TOMI Environmental Eyes Massive Expansion Opportunity as Food Industry Seeks Advanced Protection Against Emerging Pathogens
02/06/2026
Massive Food Safety Market Opens for SteraMist® as Global Concern Over Ebola, Hantavirus, Norovirus and Other Emerging Pathogens Drives Demand for Scalable Decontamination Technology Across the More Than $1 Trillion [...]
Premier Health of America Announces Anticipated Delay in Filing Interim Financial Statements and Application for Management Cease Trade Order
02/06/2026
MONTREAL, June 02, 2026 (GLOBE NEWSWIRE) -- PREMIER HEALTH OF AMERICA (TSX-V: PHA) ( “Premier Health” , or the “Company” ) announces that the Company’s unaudited interim financial statements and the related management’s [...]
Microbot Medical® Secures the First Healthcare System in North Carolina to Adopt the LIBERTY® Endovascular Robotic System
02/06/2026
A leading academic center becomes the first user in the Southeast, Mid-Atlantic region HINGHAM, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative [...]
Bay Area Lyme Ventures Invests in Galaxy Diagnostics to Advance Tick-Borne Disease Testing
02/06/2026
Partnership Aims to Accelerate Innovation in Diagnostic Tools for Patients with Complex Tick and Vector-Borne Illnesses DURHAM, NC., June 02, 2026 (GLOBE NEWSWIRE) -- Galaxy Diagnostics , a leader in advanced vector- [...]
ASHA: This Summer, Protect Your Hearing Without Missing the Fun
02/06/2026
From Fireworks to Sports and Concerts, Simple Steps Can Help Protect Your Hearing Rockville, MD, June 02, 2026 (GLOBE NEWSWIRE) -- With a summer packed full of events and activities—World Cup matches, July 4th and [...]
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Advancing Proprietary Solutions Focused on Nanotechnology-Enabled Drug Delivery, AI-Enhanced Biomedical Infrastructure
02/06/2026
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic [...]
Scene Health Releases New Guide on Medication Adherence Support for Leaders Advancing Rural Health Transformation
02/06/2026
BALTIMORE, June 02, 2026 (GLOBE NEWSWIRE) -- Scene Health announces the release of its new guide, Transforming Rural Healthcare through Medication Adherence Support , designed for U.S. health leaders strengthening their [...]
HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm
02/06/2026
Bunkerhill Health’s FDA-cleared ECG-EF algorithm for the detection of reduced ejection fraction becomes the first cleared AI-ECG algorithm available through MyoVista Insights, advancing HeartSciences’ SaaS-based, [...]
Inventiva annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris
02/06/2026
Daix (France), New York City (New York, United States), le 2 juin 2026 – Inventiva (Euronext Paris et NASDAQ: IVA ) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement d’une [...]
Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors
02/06/2026
Appointments Add Deep Biopharmaceutical Commercial Strategy, Clinical and Finance Expertise as Company Advances Toward Potential Cytisinicline Approval and Launch SEATTLE and VANCOUVER, British Columbia, June 02, 2026 ( [...]
Quoin Pharmaceuticals Submits IND Application for QRX003 in Peeling Skin Syndrome
02/06/2026
-First ever IND submission for this disease, which has no current treatment or cure- -Quoin plans Phase 2 study initiation in 2H 2026- -Submission supported by positive initial clinical data from Investigator-led [...]
Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026
02/06/2026
New findings from the industry’s largest real-world TMS database reinforce NeuroStar’s leadership in advancing evidence-based mental health care MALVERN, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ [...]
Signati™ Medical Receives FDA IDE Approval for Pivotal Study of the Separo™ Vessel Sealing System
02/06/2026
Providence, RI, June 02, 2026 (GLOBE NEWSWIRE) -- Signati™ Medical, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational Device Exemption (IDE) application for [...]
Inventiva Announces Trading Resumption of its Ordinary Shares on Euronext Paris
02/06/2026
Daix (France), New York City (New York, United States), June 2, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA ) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of [...]
Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website
02/06/2026
New dashboard at betabionics.com shows every patient, every baseline, every outcome, with no filters and no fine print IRVINE, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering [...]

Pages